CLINICAL_TRIALS
trial_result
· 2022-03-22
Clinical Trial Update: Evaluation of Votrient in Angiosarcoma [Phase 2]
Summary
Phase 2 trial evaluating Votrient (pazopanib) in angiosarcoma; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Heidelberg University | Conditions: Angiosarcoma | Phase 2 | Status: TERMINATED | Results posted: 2022-03-22